PA
PBYI icon

Profund Advisors’s Puma Biotechnology PBYI Stock Holding History

Profund Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,706
Closed -$379K – 1456
2016
Q2 		$379K Buy
12,706
+202
+2% +$6.32K 0.02% 969
2016
Q1 		$367K Sell
12,504
-3,001
-19% -$136K 0.02% 946
2015
Q4 		$1.22M Sell
15,505
-43
-0.3% -$3.38K 0.06% 296
2015
Q3 		$1.17M Sell
15,548
-386
-2% -$36.5K 0.07% 248
2015
Q2 		$1.86M Sell
15,934
-1,010
-6% -$183K 0.08% 198
2015
Q1 		$4M Buy
16,944
+2,690
+19% +$575K 0.16% 91
2014
Q4 		$2.7M Buy
14,254
+1,420
+11% +$315K 0.11% 144
2014
Q3 		$3.06M Buy
+12,834
New +$2.64M 0.14% 112

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Profund Advisors's PBYI Position: Q3 2016 in Review

Profund Advisors sold out of Puma Biotechnology (PBYI) in Q3 2016, closing a stake of 12,706 shares — an estimated $379K sold.

Profund Advisors first reported a position in PBYI in Q3 2014 and held it in 8 quarters. The position peaked at $4M in Q1 2015. 149 funds tracked by Wall St. Rank hold PBYI as of Q3 2016.

  • Profund Advisors reported no remaining Puma Biotechnology position as of Q3 2016 after selling out during the quarter.
  • Profund Advisors sold 12,706 Puma Biotechnology shares in Q3 2016, an estimated $379K.
  • Profund Advisors first reported a position in Puma Biotechnology in Q3 2014 and held it in 8 quarters.
  • Profund Advisors's Puma Biotechnology position peaked at $4M in Q1 2015.
  • 149 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2016.

Based on Profund Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.